Yaqi Lv
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Discovery top 1%
Papers in
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Lifang Yin (13 shared papers)Yiao Wang (3 shared papers)Lifang Fan (2 shared papers)Jin Zhu (1 shared paper)Chao Qin (1 shared paper)Shumin Zhu (1 shared paper)Ke Yang (1 shared paper)Wei He (1 shared paper)
- Journals
- International Journal of Pharmaceutics (5 papers)Scientific Reports (2 papers)BMC Medical Research Methodology (2 papers)Advanced Science (1 paper)Geriatrics and gerontology international (1 paper)
- Partner nations
- ChinaSaudi ArabiaUnited States
In The Last Decade
Yaqi Lv
25 papers receiving 1.7k citations
Yaqi Lv's Hit Papers
Peers
Comparison fields: 5 of 153
- Pharmaceutical Science 392
- Drug Discovery 7
- Biomaterials 461
- Molecular Medicine 75
- Pharmacology 71
Countries citing papers authored by Yaqi Lv
This map shows the geographic impact of Yaqi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqi Lv more than expected).
Fields of papers citing papers by Yaqi Lv
This network shows the impact of papers produced by Yaqi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqi Lv. The network helps show where Yaqi Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaqi Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | International Journal of Pharmaceutics Hit paper breakdown → | 2015 | 996 |
| 2 | 2018 | 209 | |
| 3 | 2017 | 79 | |
| 4 | 2018 | 73 | |
| 5 | 2014 | 69 | |
| 6 | 2017 | 52 | |
| 7 | 2016 | 47 | |
| 8 | 2015 | 46 | |
| 9 | 2015 | 25 | |
| 10 | 2015 | 23 | |
| 11 | 2020 | 22 | |
| 12 | 2018 | 20 | |
| 13 | 2017 | 18 | |
| 14 | 2016 | 17 | |
| 15 | 2014 | 13 | |
| 16 | 2018 | 11 | |
| 17 | 2016 | 11 | |
| 18 | 2014 | 11 | |
| 19 | 2017 | 11 | |
| 20 | 2018 | 10 |
About Yaqi Lv
Yaqi Lv is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Cancer Research and Pharmaceutical Science, having authored 25 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (4 papers), Clinical Laboratory Practices and Quality Control (3 papers), Advanced Drug Delivery Systems (3 papers), Nanoplatforms for cancer theranostics (3 papers), Drug Solubulity and Delivery Systems (2 papers), Ruminant Nutrition and Digestive Physiology (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Pharmaceutical Science (392 citations), Drug Discovery (7 citations), Biomaterials (461 citations), Molecular Medicine (75 citations) and Pharmacology (71 citations). Yaqi Lv has collaborated with scholars based in China, Saudi Arabia and United States. Frequent co-authors include Lifang Yin, Yiao Wang, Lifang Fan, Jin Zhu, Chao Qin, Shumin Zhu, Ke Yang, Wei He, Wei He and Chao Qin. Their work appears in journals such as International Journal of Pharmaceutics, Scientific Reports, BMC Medical Research Methodology, Advanced Science and Geriatrics and gerontology international.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.